News and Events

NJ Bio, an expert in bioconjugation, nucleotide chemistry, custom synthesis, flow chemistry and process development, and application of BioNMR to drug discovery programs, is moving to new, state-of-the-art headquarters in Princeton, NJ.

NJ Bio has published a review article on Antibody-Oligonucleotide Conjugates. Dugal-Tessier, J.; Thirumalairajan, S.; Jain, N. Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates. J. Clin. Med 2021,10, 838. https://doi.org/10.3390/jcm10040838...

North Brunswick, NJ and Bristol, PA — NJ Biopharmaceuticals LLC (d/b/a NJ Bio), a CRO providing integrated chemistry and biology services, was awarded Runner Up in the Best Contract Research Provider category at the 7th Annual World ADC Awards. The Best CRO Provider...

SAN CARLOS, Calif. and NEW BRUNSWICK, N.J. — LakePharma, Inc., the leading US-based biologics CRDMO, and NJ Biopharmaceuticals LLC (d/b/a NJ Bio), a CRO providing integrated chemistry and biology services, today announce the formation of a strategic alliance to offer...

NJ Bio would like to share that Dr. Naresh Jain, NJ Bio’s President & CEO, and Dr. Julien Dugal-Tessier, NJ Bio’s Director of Innovative Chemistry and Innovation, will hold a Workshop at the 10th Annual World ADC London 2020. The workshop will be titled “The...

Dr. Naresh Jain, NJ Bio’s President & CEO, has been presented with this year’s UAA-ICT Distinguished Alumnus Award in the Research Category by the UDCT Alumni Association (UAA). This prestigious award, given out annually in five categories, was awarded to Dr. Jain...

NJ Bio is pleased to announce that Dr. Jagath Reddy Junutula and Dr Zhihua Sui two well-known and esteemed industry experts in oncology drug discovery (including ADCs) and medicinal chemistry/drug discovery, respectively, have joined NJ Bio’s Scientific Advisory Board...

NJ Bio will exhibit at the 10th annual World ADC 2019 in San Diego, CA, from October 10 – 11, 2019. World ADC, organized by Hanson Wade, is the longest standing and most comprehensive antibody-drug conjugate meeting. Please visit us at our booth to discuss...

Dr. Naresh Jain, President & CEO of NJ Bio, will speak of Friday, October 11, 2019, at 9:10 am at World ADC 2019 in San Diego. The topic of Dr. Jain’s talk will be “Protoxins: The Next Generation of Toxins for Antibody-Drug Conjugates.” The presentation will cover...

Philadelphia Regional Integrated Medicine Alliance (“PRIMA”) NJ Biop has joined the Greater Philadelphia Regional Integrated Medicine Alliance (PRIMA). PRIMA is a regional, integrated and virtual public/private partnership focused exclusively on nurturing the region’s...